Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1990 1
1992 2
1993 2
1994 1
1995 2
1996 1
1997 1
1998 3
1999 1
2000 2
2001 2
2002 1
2004 2
2005 4
2006 3
2007 3
2008 1
2009 3
2010 5
2011 2
2012 3
2013 2
2014 4
2015 1
2016 5
2017 4
2018 3
2019 3
2020 3
2021 1
2022 1
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Endemic African Kaposi Sarcoma"
Page 1
Kaposi Sarcoma Updates.
Etemad SA, Dewan AK. Etemad SA, et al. Dermatol Clin. 2019 Oct;37(4):505-517. doi: 10.1016/j.det.2019.05.008. Epub 2019 Jul 10. Dermatol Clin. 2019. PMID: 31466590 Review.
Kaposi sarcoma (KS) is an angioproliferative mesenchymal neoplasm caused by Kaposi sarcoma-related herpesvirus. ...Recent research has informed a more comprehensive understanding of the epidemiology of KS in the post-antiretroviral therapy era, …
Kaposi sarcoma (KS) is an angioproliferative mesenchymal neoplasm caused by Kaposi sarcoma-related herpesvirus. …
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis.
Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment–2017; Ahmad N, Ahuja SD, Akkerman OW, Alffenaar JC, Anderson LF, Baghaei P, Bang D, Barry PM, Bastos ML, Behera D, Benedetti A, Bisson GP, Boeree MJ, Bonnet M, Brode SK, Brust JCM, Cai Y, Caumes E, Cegielski JP, Centis R, Chan PC, Chan ED, Chang KC, Charles M, Cirule A, Dalcolmo MP, D'Ambrosio L, de Vries G, Dheda K, Esmail A, Flood J, Fox GJ, Fréchet-Jachym M, Fregona G, Gayoso R, Gegia M, Gler MT, Gu S, Guglielmetti L, Holtz TH, Hughes J, Isaakidis P, Jarlsberg L, Kempker RR, Keshavjee S, Khan FA, Kipiani M, Koenig SP, Koh WJ, Kritski A, Kuksa L, Kvasnovsky CL, Kwak N, Lan Z, Lange C, Laniado-Laborín R, Lee M, Leimane V, Leung CC, Leung EC, Li PZ, Lowenthal P, Maciel EL, Marks SM, Mase S, Mbuagbaw L, Migliori GB, Milanov V, Miller AC, Mitnick CD, Modongo C, Mohr E, Monedero I, Nahid P, Ndjeka N, O'Donnell MR, Padayatchi N, Palmero D, Pape JW, Podewils LJ, Reynolds I, Riekstina V, Robert J, Rodriguez M, Seaworth B, Seung KJ, Schnippel K, Shim TS, Singla R, Smith SE, Sotgiu G, Sukhbaatar G, Tabarsi P, Tiberi S, Trajman A, Trieu L, Udwadia ZF, van der Werf TS, Veziris N, Viiklepp P, Vilbrun SC,… See abstract for full author list ➔ Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment–2017, et al. Lancet. 2018 Sep 8;392(10150):821-834. doi: 10.1016/S0140-6736(18)31644-1. Lancet. 2018. PMID: 30215381 Free PMC article. Review.
We used anonymised individual patient data from eligible studies, provided by study investigators, regarding clinical characteristics, treatment, and outcomes. Using propensity score-matched generalised mixed effects logistic, or linear regression, we calculated adjusted o …
We used anonymised individual patient data from eligible studies, provided by study investigators, regarding clinical characteristics …
Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis.
Müller M, Wandel S, Colebunders R, Attia S, Furrer H, Egger M; IeDEA Southern and Central Africa. Müller M, et al. Lancet Infect Dis. 2010 Apr;10(4):251-61. doi: 10.1016/S1473-3099(10)70026-8. Lancet Infect Dis. 2010. PMID: 20334848 Free PMC article. Review.
We calculated pooled cumulative incidences with 95% credibility intervals (CrI) by Bayesian methods and did a random-effects metaregression to analyse the relation between CD4 cell count and incidence of IRIS. In patients with previously diagnosed AIDS-defining illnesses, …
We calculated pooled cumulative incidences with 95% credibility intervals (CrI) by Bayesian methods and did a random-effects metaregr …
Kaposi's sarcoma revisited.
Szajerka T, Jablecki J. Szajerka T, et al. AIDS Rev. 2007 Oct-Dec;9(4):230-6. AIDS Rev. 2007. PMID: 18219366 Review.
Kaposi's sarcoma is a puzzling condition of unclear, possibly endothelial origin. ...Also, iron exposure of populations inhabiting regions with volcanic soils has been suggested to play a pivotal role in the classic and endemic Kaposi's sarcoma …
Kaposi's sarcoma is a puzzling condition of unclear, possibly endothelial origin. ...Also, iron exposure of populations inhabi …
Oral HIV-associated Kaposi sarcoma.
Pantanowitz L, Khammissa RA, Lemmer J, Feller L. Pantanowitz L, et al. J Oral Pathol Med. 2013 Mar;42(3):201-7. doi: 10.1111/j.1600-0714.2012.01180.x. Epub 2012 Jun 5. J Oral Pathol Med. 2013. PMID: 22672182 Review.
Kaposi sarcoma (KS), an AIDS defining condition, remains one of the most commonly HIV-associated neoplasms. While the use of highly active antiretroviral therapy (HAART) has brought about a dramatic decrease in the prevalence and incidence of AIDS-KS worldwide, this …
Kaposi sarcoma (KS), an AIDS defining condition, remains one of the most commonly HIV-associated neoplasms. While the use of h …
CE: HIV-Associated Kaposi Sarcoma in the Combination Antiretroviral Therapy Era.
Mangusan RF, Ekwede I, Widell A. Mangusan RF, et al. Am J Nurs. 2022 Dec 1;122(12):32-40. doi: 10.1097/01.NAJ.0000901848.07128.92. Am J Nurs. 2022. PMID: 36321823 Free PMC article.
Its occurrence is associated with an immunocompromised state. Kaposi sarcoma that occurs among people living with HIV (PLWH) is known as epidemic Kaposi sarcoma. ...Here, the authors describe Kaposi sarcoma in general as well as th …
Its occurrence is associated with an immunocompromised state. Kaposi sarcoma that occurs among people living with HIV ( …
Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8): epidemiology and pathogenesis.
Schulz TF. Schulz TF. J Antimicrob Chemother. 2000 Apr;45 Suppl T3:15-27. doi: 10.1093/jac/45.suppl_4.15. J Antimicrob Chemother. 2000. PMID: 10855768 Review.
Kaposi's sarcoma-associated herpesvirus (KSHV), or human herpesvirus type 8 (HHV-8), is a gamma2 herpesvirus (rhadinovirus) and the most recently discovered human tumour virus. It is involved in the pathogenesis of Kaposi's sarcoma (KS), primary effusi …
Kaposi's sarcoma-associated herpesvirus (KSHV), or human herpesvirus type 8 (HHV-8), is a gamma2 herpesvirus (rhadinovirus) an …
AIDS-related Kaposi's sarcoma: epidemiological, diagnostic, treatment and control aspects in sub-Saharan Africa.
Sissolak G, Mayaud P. Sissolak G, et al. Trop Med Int Health. 2005 Oct;10(10):981-92. doi: 10.1111/j.1365-3156.2005.01491.x. Trop Med Int Health. 2005. PMID: 16185232 Free article. Review.
Until the 1980s, little attention had been accorded to endemic Kaposi's sarcoma (KS), a neoplasm noted in several parts of Southern Europe and the African continent but with relatively slow progression, except in children and young adults. ...
Until the 1980s, little attention had been accorded to endemic Kaposi's sarcoma (KS), a neoplasm noted in several parts …
Kaposi's sarcoma in sub-Saharan Africa: a current perspective.
Mosam A, Aboobaker J, Shaik F. Mosam A, et al. Curr Opin Infect Dis. 2010 Apr;23(2):119-23. doi: 10.1097/QCO.0b013e328335b01a. Curr Opin Infect Dis. 2010. PMID: 19996745 Review.
PURPOSE OF REVIEW: The aim of this review is to summarize the most recent published literature on HIV/AIDS Kaposi's sarcoma in sub-Saharan Africa (SSA). We attempted to update readers on the epidemiology of Kaposi's sarcoma herpesvirus infection …
PURPOSE OF REVIEW: The aim of this review is to summarize the most recent published literature on HIV/AIDS Kaposi's sarcoma in …
EPHA2 sequence variants are associated with susceptibility to Kaposi's sarcoma-associated herpesvirus infection and Kaposi's sarcoma prevalence in HIV-infected patients.
Blumenthal MJ, Schutz C, Meintjes G, Mohamed Z, Mendelson M, Ambler JM, Whitby D, Mackelprang RD, Carse S, Katz AA, Schäfer G. Blumenthal MJ, et al. Cancer Epidemiol. 2018 Oct;56:133-139. doi: 10.1016/j.canep.2018.08.005. Epub 2018 Aug 31. Cancer Epidemiol. 2018. PMID: 30176543 Free PMC article. Clinical Trial.
BACKGROUND: To determine if variations exist in the KSHV host receptor EPHA2's coding region that affect KSHV infectivity and/or KS prevalence among South African HIV-infected patients. METHODS: A retrospective candidate gene association study was performed on 150 patients …
BACKGROUND: To determine if variations exist in the KSHV host receptor EPHA2's coding region that affect KSHV infectivity and/or KS prevalen …
68 results